Development
Dolby Laboratories, Inc.
DLB
$71.98
-$0.36-0.50%
NYSE
| 12/29/2023 | 09/29/2023 | 06/30/2023 | 03/31/2023 | 12/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 188.26M | 200.66M | 219.23M | 242.42M | 183.45M |
| Total Depreciation and Amortization | 94.11M | 95.51M | 93.83M | 96.78M | 98.55M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 116.62M | 112.91M | 94.25M | 78.11M | 80.62M |
| Change in Net Operating Assets | -79.90M | -42.00M | -73.92M | -32.46M | -19.30M |
| Cash from Operations | 319.10M | 367.08M | 333.38M | 384.85M | 343.31M |
| Capital Expenditure | -29.22M | -30.34M | -32.86M | -36.62M | -40.69M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 25.70M | 25.70M | 25.70M | 57.00K | -38.17M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 30.06M | 58.84M | 40.36M | 39.56M | -62.66M |
| Cash from Investing | 26.54M | 54.21M | 33.20M | 3.00M | -141.52M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 55.85M | 47.78M | 41.48M | 44.18M | 47.43M |
| Repurchase of Common Stock | -220.57M | -180.42M | -375.32M | -539.77M | -573.82M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -106.09M | -103.41M | -101.84M | -101.13M | -100.65M |
| Other Financing Activities | -1.05M | -766.00K | -766.00K | -766.00K | -766.00K |
| Cash from Financing | -271.86M | -236.81M | -436.44M | -597.49M | -627.81M |
| Foreign Exchange rate Adjustments | 3.41M | 5.12M | 1.77M | -5.79M | -6.93M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 77.18M | 189.60M | -68.10M | -215.42M | -432.96M |